Digital Pathology Systems-Europe Market Status and Trend Report 2013-2023
Report Summary
Digital Pathology Systems-Europe Market Status and Trend Report 2013-2023 offers a comprehensive analysis on Digital Pathology Systems industry, standing on the readers’ perspective, delivering detailed market data and penetrating insights. No matter the client is industry insider, potential entrant or investor, the report will provides useful data and information. Key questions answered by this report include:
Whole Europe and Regional Market Size of Digital Pathology Systems 2013-2017, and development forecast 2018-2023
Main market players of Digital Pathology Systems in Europe, with company and product introduction, position in the Digital Pathology Systems market
Market status and development trend of Digital Pathology Systems by types and applications
Cost and profit status of Digital Pathology Systems, and marketing status
Market growth drivers and challenges
The report segments the Europe Digital Pathology Systems market as:
Europe Digital Pathology Systems Market: Regional Segment Analysis (Regional Consumption Volume, Consumption Volume, Revenue and Growth Rate 2013-2023):
Germany
United Kingdom
France
Italy
Spain
Benelux
Russia
Europe Digital Pathology Systems Market: Product Type Segment Analysis (Consumption Volume, Average Price, Revenue, Market Share and Trend 2013-2023):
Static Telepathology
Dynamic Telepathology
Hybrid Telepathology
Europe Digital Pathology Systems Market: Application Segment Analysis (Consumption Volume and Market Share 2013-2023; Downstream Customers and Market Analysis)
Disease Diagnosis
Academic Research
Drug Discovery and Development
Europe Digital Pathology Systems Market: Players Segment Analysis (Company and Product introduction, Digital Pathology Systems Sales Volume, Revenue, Price and Gross Margin):
3Dhistech Ltd (Hungary)
Apollo Enterprise Imaging Corp (USA)
Carl Zeiss AG (Germany)
Corista LLC (USA)
Definiens AG (Germany)
Hamamatsu Photonics K.K. (Japan)
Huron Digital Pathology, Inc (Canada)
Leica Biosystems Nussloch GmbH (Germany)
MikroScan Technologies, Inc (USA)
Olympus Corporation (Japan)
Philips Healthcare (Netherlands)
Pixcelldata Ltd. (Ireland)
Ventana Medical Systems, Inc (USA)
VMscope GmbH (Germany)
In a word, the report provides detailed statistics and analysis on the state of the industry; and is a valuable source of guidance and direction for companies and individuals interested in the market.
Digital Pathology Systems-Europe Market Status and Trend Report 2013-2023 offers a comprehensive analysis on Digital Pathology Systems industry, standing on the readers’ perspective, delivering detailed market data and penetrating insights. No matter the client is industry insider, potential entrant or investor, the report will provides useful data and information. Key questions answered by this report include:
Whole Europe and Regional Market Size of Digital Pathology Systems 2013-2017, and development forecast 2018-2023
Main market players of Digital Pathology Systems in Europe, with company and product introduction, position in the Digital Pathology Systems market
Market status and development trend of Digital Pathology Systems by types and applications
Cost and profit status of Digital Pathology Systems, and marketing status
Market growth drivers and challenges
The report segments the Europe Digital Pathology Systems market as:
Europe Digital Pathology Systems Market: Regional Segment Analysis (Regional Consumption Volume, Consumption Volume, Revenue and Growth Rate 2013-2023):
Germany
United Kingdom
France
Italy
Spain
Benelux
Russia
Europe Digital Pathology Systems Market: Product Type Segment Analysis (Consumption Volume, Average Price, Revenue, Market Share and Trend 2013-2023):
Static Telepathology
Dynamic Telepathology
Hybrid Telepathology
Europe Digital Pathology Systems Market: Application Segment Analysis (Consumption Volume and Market Share 2013-2023; Downstream Customers and Market Analysis)
Disease Diagnosis
Academic Research
Drug Discovery and Development
Europe Digital Pathology Systems Market: Players Segment Analysis (Company and Product introduction, Digital Pathology Systems Sales Volume, Revenue, Price and Gross Margin):
3Dhistech Ltd (Hungary)
Apollo Enterprise Imaging Corp (USA)
Carl Zeiss AG (Germany)
Corista LLC (USA)
Definiens AG (Germany)
Hamamatsu Photonics K.K. (Japan)
Huron Digital Pathology, Inc (Canada)
Leica Biosystems Nussloch GmbH (Germany)
MikroScan Technologies, Inc (USA)
Olympus Corporation (Japan)
Philips Healthcare (Netherlands)
Pixcelldata Ltd. (Ireland)
Ventana Medical Systems, Inc (USA)
VMscope GmbH (Germany)
In a word, the report provides detailed statistics and analysis on the state of the industry; and is a valuable source of guidance and direction for companies and individuals interested in the market.
CHAPTER 1 OVERVIEW OF DIGITAL PATHOLOGY SYSTEMS
1.1 Definition of Digital Pathology Systems in This Report
1.2 Commercial Types of Digital Pathology Systems
1.2.1 Static Telepathology
1.2.2 Dynamic Telepathology
1.2.3 Hybrid Telepathology
1.3 Downstream Application of Digital Pathology Systems
1.3.1 Disease Diagnosis
1.3.2 Academic Research
1.3.3 Drug Discovery and Development
1.4 Development History of Digital Pathology Systems
1.5 Market Status and Trend of Digital Pathology Systems 2013-2023
1.5.1 Europe Digital Pathology Systems Market Status and Trend 2013-2023
1.5.2 Regional Digital Pathology Systems Market Status and Trend 2013-2023
CHAPTER 2 EUROPE MARKET STATUS AND FORECAST BY REGIONS
2.1 Market Status of Digital Pathology Systems in Europe 2013-2017
2.2 Consumption Market of Digital Pathology Systems in Europe by Regions
2.2.1 Consumption Volume of Digital Pathology Systems in Europe by Regions
2.2.2 Revenue of Digital Pathology Systems in Europe by Regions
2.3 Market Analysis of Digital Pathology Systems in Europe by Regions
2.3.1 Market Analysis of Digital Pathology Systems in Germany 2013-2017
2.3.2 Market Analysis of Digital Pathology Systems in United Kingdom 2013-2017
2.3.3 Market Analysis of Digital Pathology Systems in France 2013-2017
2.3.4 Market Analysis of Digital Pathology Systems in Italy 2013-2017
2.3.5 Market Analysis of Digital Pathology Systems in Spain 2013-2017
2.3.6 Market Analysis of Digital Pathology Systems in Benelux 2013-2017
2.3.7 Market Analysis of Digital Pathology Systems in Russia 2013-2017
2.4 Market Development Forecast of Digital Pathology Systems in Europe 2018-2023
2.4.1 Market Development Forecast of Digital Pathology Systems in Europe 2018-2023
2.4.2 Market Development Forecast of Digital Pathology Systems by Regions 2018-2023
CHAPTER 3 EUROPE MARKET STATUS AND FORECAST BY TYPES
3.1 Whole Europe Market Status by Types
3.1.1 Consumption Volume of Digital Pathology Systems in Europe by Types
3.1.2 Revenue of Digital Pathology Systems in Europe by Types
3.2 Europe Market Status by Types in Major Countries
3.2.1 Market Status by Types in Germany
3.2.2 Market Status by Types in United Kingdom
3.2.3 Market Status by Types in France
3.2.4 Market Status by Types in Italy
3.2.5 Market Status by Types in Spain
3.2.6 Market Status by Types in Benelux
3.2.7 Market Status by Types in Russia
3.3 Market Forecast of Digital Pathology Systems in Europe by Types
CHAPTER 4 EUROPE MARKET STATUS AND FORECAST BY DOWNSTREAM INDUSTRY
4.1 Demand Volume of Digital Pathology Systems in Europe by Downstream Industry
4.2 Demand Volume of Digital Pathology Systems by Downstream Industry in Major Countries
4.2.1 Demand Volume of Digital Pathology Systems by Downstream Industry in Germany
4.2.2 Demand Volume of Digital Pathology Systems by Downstream Industry in United Kingdom
4.2.3 Demand Volume of Digital Pathology Systems by Downstream Industry in France
4.2.4 Demand Volume of Digital Pathology Systems by Downstream Industry in Italy
4.2.5 Demand Volume of Digital Pathology Systems by Downstream Industry in Spain
4.2.6 Demand Volume of Digital Pathology Systems by Downstream Industry in Benelux
4.2.7 Demand Volume of Digital Pathology Systems by Downstream Industry in Russia
4.3 Market Forecast of Digital Pathology Systems in Europe by Downstream Industry
CHAPTER 5 MARKET DRIVING FACTOR ANALYSIS OF DIGITAL PATHOLOGY SYSTEMS
5.1 Europe Economy Situation and Trend Overview
5.2 Digital Pathology Systems Downstream Industry Situation and Trend Overview
CHAPTER 6 DIGITAL PATHOLOGY SYSTEMS MARKET COMPETITION STATUS BY MAJOR PLAYERS IN EUROPE
6.1 Sales Volume of Digital Pathology Systems in Europe by Major Players
6.2 Revenue of Digital Pathology Systems in Europe by Major Players
6.3 Basic Information of Digital Pathology Systems by Major Players
6.3.1 Headquarters Location and Established Time of Digital Pathology Systems Major Players
6.3.2 Employees and Revenue Level of Digital Pathology Systems Major Players
6.4 Market Competition News and Trend
6.4.1 Merger, Consolidation or Acquisition News
6.4.2 Investment or Disinvestment News
6.4.3 New Product Development and Launch
CHAPTER 7 DIGITAL PATHOLOGY SYSTEMS MAJOR MANUFACTURERS INTRODUCTION AND MARKET DATA
7.1 3Dhistech Ltd (Hungary)
7.1.1 Company profile
7.1.2 Representative Digital Pathology Systems Product
7.1.3 Digital Pathology Systems Sales, Revenue, Price and Gross Margin of 3Dhistech Ltd (Hungary)
7.2 Apollo Enterprise Imaging Corp (USA)
7.2.1 Company profile
7.2.2 Representative Digital Pathology Systems Product
7.2.3 Digital Pathology Systems Sales, Revenue, Price and Gross Margin of Apollo Enterprise Imaging Corp (USA)
7.3 Carl Zeiss AG (Germany)
7.3.1 Company profile
7.3.2 Representative Digital Pathology Systems Product
7.3.3 Digital Pathology Systems Sales, Revenue, Price and Gross Margin of Carl Zeiss AG (Germany)
7.4 Corista LLC (USA)
7.4.1 Company profile
7.4.2 Representative Digital Pathology Systems Product
7.4.3 Digital Pathology Systems Sales, Revenue, Price and Gross Margin of Corista LLC (USA)
7.5 Definiens AG (Germany)
7.5.1 Company profile
7.5.2 Representative Digital Pathology Systems Product
7.5.3 Digital Pathology Systems Sales, Revenue, Price and Gross Margin of Definiens AG (Germany)
7.6 Hamamatsu Photonics K.K. (Japan)
7.6.1 Company profile
7.6.2 Representative Digital Pathology Systems Product
7.6.3 Digital Pathology Systems Sales, Revenue, Price and Gross Margin of Hamamatsu Photonics K.K. (Japan)
7.7 Huron Digital Pathology, Inc (Canada)
7.7.1 Company profile
7.7.2 Representative Digital Pathology Systems Product
7.7.3 Digital Pathology Systems Sales, Revenue, Price and Gross Margin of Huron Digital Pathology, Inc (Canada)
7.8 Leica Biosystems Nussloch GmbH (Germany)
7.8.1 Company profile
7.8.2 Representative Digital Pathology Systems Product
7.8.3 Digital Pathology Systems Sales, Revenue, Price and Gross Margin of Leica Biosystems Nussloch GmbH (Germany)
7.9 MikroScan Technologies, Inc (USA)
7.9.1 Company profile
7.9.2 Representative Digital Pathology Systems Product
7.9.3 Digital Pathology Systems Sales, Revenue, Price and Gross Margin of MikroScan Technologies, Inc (USA)
7.10 Olympus Corporation (Japan)
7.10.1 Company profile
7.10.2 Representative Digital Pathology Systems Product
7.10.3 Digital Pathology Systems Sales, Revenue, Price and Gross Margin of Olympus Corporation (Japan)
7.11 Philips Healthcare (Netherlands)
7.11.1 Company profile
7.11.2 Representative Digital Pathology Systems Product
7.11.3 Digital Pathology Systems Sales, Revenue, Price and Gross Margin of Philips Healthcare (Netherlands)
7.12 Pixcelldata Ltd. (Ireland)
7.12.1 Company profile
7.12.2 Representative Digital Pathology Systems Product
7.12.3 Digital Pathology Systems Sales, Revenue, Price and Gross Margin of Pixcelldata Ltd. (Ireland)
7.13 Ventana Medical Systems, Inc (USA)
7.13.1 Company profile
7.13.2 Representative Digital Pathology Systems Product
7.13.3 Digital Pathology Systems Sales, Revenue, Price and Gross Margin of Ventana Medical Systems, Inc (USA)
7.14 VMscope GmbH (Germany)
7.14.1 Company profile
7.14.2 Representative Digital Pathology Systems Product
7.14.3 Digital Pathology Systems Sales, Revenue, Price and Gross Margin of VMscope GmbH (Germany)
CHAPTER 8 UPSTREAM AND DOWNSTREAM MARKET ANALYSIS OF DIGITAL PATHOLOGY SYSTEMS
8.1 Industry Chain of Digital Pathology Systems
8.2 Upstream Market and Representative Companies Analysis
8.3 Downstream Market and Representative Companies Analysis
CHAPTER 9 COST AND GROSS MARGIN ANALYSIS OF DIGITAL PATHOLOGY SYSTEMS
9.1 Cost Structure Analysis of Digital Pathology Systems
9.2 Raw Materials Cost Analysis of Digital Pathology Systems
9.3 Labor Cost Analysis of Digital Pathology Systems
9.4 Manufacturing Expenses Analysis of Digital Pathology Systems
CHAPTER 10 MARKETING STATUS ANALYSIS OF DIGITAL PATHOLOGY SYSTEMS
10.1 Marketing Channel
10.1.1 Direct Marketing
10.1.2 Indirect Marketing
10.1.3 Marketing Channel Development Trend
10.2 Market Positioning
10.2.1 Pricing Strategy
10.2.2 Brand Strategy
10.2.3 Target Client
10.3 Distributors/Traders List
CHAPTER 11 REPORT CONCLUSION
CHAPTER 12 RESEARCH METHODOLOGY AND REFERENCE
12.1 Methodology/Research Approach
12.1.1 Research Programs/Design
12.1.2 Market Size Estimation
12.1.3 Market Breakdown and Data Triangulation
12.2 Data Source
12.2.1 Secondary Sources
12.2.2 Primary Sources
12.3 Reference
1.1 Definition of Digital Pathology Systems in This Report
1.2 Commercial Types of Digital Pathology Systems
1.2.1 Static Telepathology
1.2.2 Dynamic Telepathology
1.2.3 Hybrid Telepathology
1.3 Downstream Application of Digital Pathology Systems
1.3.1 Disease Diagnosis
1.3.2 Academic Research
1.3.3 Drug Discovery and Development
1.4 Development History of Digital Pathology Systems
1.5 Market Status and Trend of Digital Pathology Systems 2013-2023
1.5.1 Europe Digital Pathology Systems Market Status and Trend 2013-2023
1.5.2 Regional Digital Pathology Systems Market Status and Trend 2013-2023
CHAPTER 2 EUROPE MARKET STATUS AND FORECAST BY REGIONS
2.1 Market Status of Digital Pathology Systems in Europe 2013-2017
2.2 Consumption Market of Digital Pathology Systems in Europe by Regions
2.2.1 Consumption Volume of Digital Pathology Systems in Europe by Regions
2.2.2 Revenue of Digital Pathology Systems in Europe by Regions
2.3 Market Analysis of Digital Pathology Systems in Europe by Regions
2.3.1 Market Analysis of Digital Pathology Systems in Germany 2013-2017
2.3.2 Market Analysis of Digital Pathology Systems in United Kingdom 2013-2017
2.3.3 Market Analysis of Digital Pathology Systems in France 2013-2017
2.3.4 Market Analysis of Digital Pathology Systems in Italy 2013-2017
2.3.5 Market Analysis of Digital Pathology Systems in Spain 2013-2017
2.3.6 Market Analysis of Digital Pathology Systems in Benelux 2013-2017
2.3.7 Market Analysis of Digital Pathology Systems in Russia 2013-2017
2.4 Market Development Forecast of Digital Pathology Systems in Europe 2018-2023
2.4.1 Market Development Forecast of Digital Pathology Systems in Europe 2018-2023
2.4.2 Market Development Forecast of Digital Pathology Systems by Regions 2018-2023
CHAPTER 3 EUROPE MARKET STATUS AND FORECAST BY TYPES
3.1 Whole Europe Market Status by Types
3.1.1 Consumption Volume of Digital Pathology Systems in Europe by Types
3.1.2 Revenue of Digital Pathology Systems in Europe by Types
3.2 Europe Market Status by Types in Major Countries
3.2.1 Market Status by Types in Germany
3.2.2 Market Status by Types in United Kingdom
3.2.3 Market Status by Types in France
3.2.4 Market Status by Types in Italy
3.2.5 Market Status by Types in Spain
3.2.6 Market Status by Types in Benelux
3.2.7 Market Status by Types in Russia
3.3 Market Forecast of Digital Pathology Systems in Europe by Types
CHAPTER 4 EUROPE MARKET STATUS AND FORECAST BY DOWNSTREAM INDUSTRY
4.1 Demand Volume of Digital Pathology Systems in Europe by Downstream Industry
4.2 Demand Volume of Digital Pathology Systems by Downstream Industry in Major Countries
4.2.1 Demand Volume of Digital Pathology Systems by Downstream Industry in Germany
4.2.2 Demand Volume of Digital Pathology Systems by Downstream Industry in United Kingdom
4.2.3 Demand Volume of Digital Pathology Systems by Downstream Industry in France
4.2.4 Demand Volume of Digital Pathology Systems by Downstream Industry in Italy
4.2.5 Demand Volume of Digital Pathology Systems by Downstream Industry in Spain
4.2.6 Demand Volume of Digital Pathology Systems by Downstream Industry in Benelux
4.2.7 Demand Volume of Digital Pathology Systems by Downstream Industry in Russia
4.3 Market Forecast of Digital Pathology Systems in Europe by Downstream Industry
CHAPTER 5 MARKET DRIVING FACTOR ANALYSIS OF DIGITAL PATHOLOGY SYSTEMS
5.1 Europe Economy Situation and Trend Overview
5.2 Digital Pathology Systems Downstream Industry Situation and Trend Overview
CHAPTER 6 DIGITAL PATHOLOGY SYSTEMS MARKET COMPETITION STATUS BY MAJOR PLAYERS IN EUROPE
6.1 Sales Volume of Digital Pathology Systems in Europe by Major Players
6.2 Revenue of Digital Pathology Systems in Europe by Major Players
6.3 Basic Information of Digital Pathology Systems by Major Players
6.3.1 Headquarters Location and Established Time of Digital Pathology Systems Major Players
6.3.2 Employees and Revenue Level of Digital Pathology Systems Major Players
6.4 Market Competition News and Trend
6.4.1 Merger, Consolidation or Acquisition News
6.4.2 Investment or Disinvestment News
6.4.3 New Product Development and Launch
CHAPTER 7 DIGITAL PATHOLOGY SYSTEMS MAJOR MANUFACTURERS INTRODUCTION AND MARKET DATA
7.1 3Dhistech Ltd (Hungary)
7.1.1 Company profile
7.1.2 Representative Digital Pathology Systems Product
7.1.3 Digital Pathology Systems Sales, Revenue, Price and Gross Margin of 3Dhistech Ltd (Hungary)
7.2 Apollo Enterprise Imaging Corp (USA)
7.2.1 Company profile
7.2.2 Representative Digital Pathology Systems Product
7.2.3 Digital Pathology Systems Sales, Revenue, Price and Gross Margin of Apollo Enterprise Imaging Corp (USA)
7.3 Carl Zeiss AG (Germany)
7.3.1 Company profile
7.3.2 Representative Digital Pathology Systems Product
7.3.3 Digital Pathology Systems Sales, Revenue, Price and Gross Margin of Carl Zeiss AG (Germany)
7.4 Corista LLC (USA)
7.4.1 Company profile
7.4.2 Representative Digital Pathology Systems Product
7.4.3 Digital Pathology Systems Sales, Revenue, Price and Gross Margin of Corista LLC (USA)
7.5 Definiens AG (Germany)
7.5.1 Company profile
7.5.2 Representative Digital Pathology Systems Product
7.5.3 Digital Pathology Systems Sales, Revenue, Price and Gross Margin of Definiens AG (Germany)
7.6 Hamamatsu Photonics K.K. (Japan)
7.6.1 Company profile
7.6.2 Representative Digital Pathology Systems Product
7.6.3 Digital Pathology Systems Sales, Revenue, Price and Gross Margin of Hamamatsu Photonics K.K. (Japan)
7.7 Huron Digital Pathology, Inc (Canada)
7.7.1 Company profile
7.7.2 Representative Digital Pathology Systems Product
7.7.3 Digital Pathology Systems Sales, Revenue, Price and Gross Margin of Huron Digital Pathology, Inc (Canada)
7.8 Leica Biosystems Nussloch GmbH (Germany)
7.8.1 Company profile
7.8.2 Representative Digital Pathology Systems Product
7.8.3 Digital Pathology Systems Sales, Revenue, Price and Gross Margin of Leica Biosystems Nussloch GmbH (Germany)
7.9 MikroScan Technologies, Inc (USA)
7.9.1 Company profile
7.9.2 Representative Digital Pathology Systems Product
7.9.3 Digital Pathology Systems Sales, Revenue, Price and Gross Margin of MikroScan Technologies, Inc (USA)
7.10 Olympus Corporation (Japan)
7.10.1 Company profile
7.10.2 Representative Digital Pathology Systems Product
7.10.3 Digital Pathology Systems Sales, Revenue, Price and Gross Margin of Olympus Corporation (Japan)
7.11 Philips Healthcare (Netherlands)
7.11.1 Company profile
7.11.2 Representative Digital Pathology Systems Product
7.11.3 Digital Pathology Systems Sales, Revenue, Price and Gross Margin of Philips Healthcare (Netherlands)
7.12 Pixcelldata Ltd. (Ireland)
7.12.1 Company profile
7.12.2 Representative Digital Pathology Systems Product
7.12.3 Digital Pathology Systems Sales, Revenue, Price and Gross Margin of Pixcelldata Ltd. (Ireland)
7.13 Ventana Medical Systems, Inc (USA)
7.13.1 Company profile
7.13.2 Representative Digital Pathology Systems Product
7.13.3 Digital Pathology Systems Sales, Revenue, Price and Gross Margin of Ventana Medical Systems, Inc (USA)
7.14 VMscope GmbH (Germany)
7.14.1 Company profile
7.14.2 Representative Digital Pathology Systems Product
7.14.3 Digital Pathology Systems Sales, Revenue, Price and Gross Margin of VMscope GmbH (Germany)
CHAPTER 8 UPSTREAM AND DOWNSTREAM MARKET ANALYSIS OF DIGITAL PATHOLOGY SYSTEMS
8.1 Industry Chain of Digital Pathology Systems
8.2 Upstream Market and Representative Companies Analysis
8.3 Downstream Market and Representative Companies Analysis
CHAPTER 9 COST AND GROSS MARGIN ANALYSIS OF DIGITAL PATHOLOGY SYSTEMS
9.1 Cost Structure Analysis of Digital Pathology Systems
9.2 Raw Materials Cost Analysis of Digital Pathology Systems
9.3 Labor Cost Analysis of Digital Pathology Systems
9.4 Manufacturing Expenses Analysis of Digital Pathology Systems
CHAPTER 10 MARKETING STATUS ANALYSIS OF DIGITAL PATHOLOGY SYSTEMS
10.1 Marketing Channel
10.1.1 Direct Marketing
10.1.2 Indirect Marketing
10.1.3 Marketing Channel Development Trend
10.2 Market Positioning
10.2.1 Pricing Strategy
10.2.2 Brand Strategy
10.2.3 Target Client
10.3 Distributors/Traders List
CHAPTER 11 REPORT CONCLUSION
CHAPTER 12 RESEARCH METHODOLOGY AND REFERENCE
12.1 Methodology/Research Approach
12.1.1 Research Programs/Design
12.1.2 Market Size Estimation
12.1.3 Market Breakdown and Data Triangulation
12.2 Data Source
12.2.1 Secondary Sources
12.2.2 Primary Sources
12.3 Reference
